Gene-modified mesenchymal stem cells protect against radiation-induced lung injury

Molecular Therapy

Volumn 21, Issue 2, 2013, Pages 456-465

  Xue, Jianxin ^a   Li, Xin ^a   Lu, You ^a   Gan, Lu ^a   Zhou, Lin ^a   Wang, Yongsheng ^a   Lan, Jie ^a   Liu, Shurui ^a   Sun, Lan ^a   Jia, Li ^a   Mo, Xianming ^a   Li, Jian ^b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ALPHA SMOOTH MUSCLE ACTIN; CELL PROTEIN; CHEMOKINE RECEPTOR CXCR4; COMPLEMENTARY DNA; CONNECTIVE TISSUE GROWTH FACTOR; GENOMIC DNA; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; KERATINOCYTE GROWTH FACTOR; MALONALDEHYDE; MESSENGER RNA; PROTEIN PROSP C; SMALL INTERFERING RNA; STROMAL CELL DERIVED FACTOR 1ALPHA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CELL MIGRATION; CELL PROTECTION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA DAMAGE; DNA MODIFICATION; DRUG EFFICACY; DRUG MECHANISM; EX VIVO STUDY; FEMALE; FUSION GENE; GENE OVEREXPRESSION; HISTOPATHOLOGY; IN VIVO STUDY; IRRADIATION; LUNG ALVEOLUS CELL TYPE 2; LUNG FIBROSIS; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PARACRINE SIGNALING; PHENOTYPE; RADIATION INDUCED LUNG INJURY; RADIATION INJURY; RADIATION PROTECTION; STEM CELL GENE THERAPY; SURVIVAL RATE; THORACIC IRRADIATION; VIRAL GENE DELIVERY SYSTEM;

EID: 84873338888     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2012.183     Document Type: Article

References (46)

1. Graves, PR, Siddiqui, F, Anscher, MS and Movsas, B (2010). Radiation pulmonary toxicity: from mechanisms to management. Semin Radiat Oncol 20: 201-207.
2. Tsoutsou, PG and Koukourakis, MI (2006). Radiation pneumonitis and fbrosis: mechanisms underlying its pathogenesis and implications for future research. Int J Radiat Oncol Biol Phys 66: 1281-1293.
3. Cappuccini, F, Eldh, T, Bruder, D, Gereke, M, Jastrow, H, Schulze-Osthoff, K et al. (2011). New insights into the molecular pathology of radiation-induced pneumopathy. Radiother Oncol 101: 86-92.
4. Zhang, M, Qian, J, Xing, X, Kong, FM, Zhao, L, Chen, M et al. (2008). Inhibition of the tumor necrosis factor-alpha pathway is radioprotective for the lung. Clin Cancer Res 14: 1868-1876.
5. Yuan, X, Liao, Z, Liu, Z, Wang, LE, Tucker, SL, Mao, L et al. (2009). Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with defnitive radiotherapy. J Clin Oncol 27: 3370-3378.
6. Xue, J, Gan, L, Li, X, Li, J, Qi, G, Wu, Y et al. (2010). Effects of lysophosphatidic acid and its receptors LPA1/3 on radiation pneumonitis. Oncol Rep 24: 1515-1520.
7. Ikushima, H and Miyazono, K (2010). TGFbeta signalling: a complex web in cancer progression. Nat Rev Cancer 10: 415-424.
8. Zhao, L, Wang, L, Ji, W, Wang, X, Zhu, X, Hayman, JA et al. (2009). Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and Michigan. Int J Radiat Oncol Biol Phys 74: 1385-1390.
9. Nishioka, A, Ogawa, Y, Mima, T, Jin, YJ, Sonobe, H, Kariya, S et al. (2004). Histopathologic amelioration of fbroproliferative change in rat irradiated lung using soluble transforming growth factor-beta (TGF-beta) receptor mediated by adenoviral vector. Int J Radiat Oncol Biol Phys 58: 1235-1241.
10. Rabbani, ZN, Anscher, MS, Zhang, X, Chen, L, Samulski, TV, Li, CY et al. (2003). Soluble TGFbeta type II receptor gene therapy ameliorates acute radiation-induced pulmonary injury in rats. Int J Radiat Oncol Biol Phys 57: 563-572.
11. Haiping, Z, Takayama, K, Uchino, J, Harada, A, Adachi, Y, Kura, S et al. (2006). Prevention of radiation-induced pneumonitis by recombinant adenovirus-mediated transferring of soluble TGF-beta type II receptor gene. Cancer Gene Ther 13: 864-872.
12. Anscher, MS, Thrasher, B, Rabbani, Z, Teicher, B and Vujaskovic, Z (2006). Antitransforming growth factor-beta antibody 1D11 ameliorates normal tissue damage caused by high-dose radiation. Int J Radiat Oncol Biol Phys 65: 876-881.
13. Karp, JM and Leng Teo, GS (2009). Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 4: 206-216.
14. D'Agostino, B, Sullo, N, Siniscalco, D, De Angelis, A and Rossi, F (2010). Mesenchymal stem cell therapy for the treatment of chronic obstructive pulmonary disease. Expert Opin Biol Ther 10: 681-687.
15. Xu, J, Woods, CR, Mora, AL, Joodi, R, Brigham, KL, Iyer, S et al. (2007). Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am J Physiol Lung Cell Mol Physiol 293: L131-L141.
16. Gupta, N, Su, X, Popov, B, Lee, JW, Serikov, V and Matthay, MA (2007). Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 179: 1855-1863.
17. Ortiz, LA, Gambelli, F, McBride, C, Gaupp, D, Baddoo, M, Kaminski, N et al. (2003). Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fbrotic effects. Proc Natl Acad Sci USA 100: 8407-8411.
18. Rojas, M, Xu, J, Woods, CR, Mora, AL, Spears, W, Roman, J et al. (2005). Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 33: 145-152.
19. van Haaften, T, Byrne, R, Bonnet, S, Rochefort, GY, Akabutu, J, Bouchentouf, M et al. (2009). Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Respir Crit Care Med 180: 1131-1142.
20. Aslam, M, Baveja, R, Liang, OD, Fernandez-Gonzalez, A, Lee, C, Mitsialis, SA et al. (2009). Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med 180: 1122-1130.
21. Gnecchi, M, He, H, Liang, OD, Melo, LG, Morello, F, Mu, H et al. (2005). Paracrine action accounts for marked protection of ischemic heart by Akt-modifed mesenchymal stem cells. Nat Med 11: 367-368.
22. Mei, SH, McCarter, SD, Deng, Y, Parker, CH, Liles, WC and Stewart, DJ (2007). Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 4: e269.
23. Aguilar, S, Scotton, CJ, McNulty, K, Nye, E, Stamp, G, Laurent, G et al. (2009). Bone marrow stem cells expressing keratinocyte growth factor via an inducible lentivirus protects against bleomycin-induced pulmonary fbrosis. PLoS ONE 4: e8013.
24. Kim, SH, Moon, HH, Kim, HA, Hwang, KC, Lee, M and Choi, D (2011). Hypoxia-inducible vascular endothelial growth factor-engineered mesenchymal stem cells prevent myocardial ischemic injury. Mol Ther 19: 741-750.
25. Liang, OD, Mitsialis, SA, Chang, MS, Vergadi, E, Lee, C, Aslam, M et al. (2011). Mesenchymal stromal cells expressing heme oxygenase-1 reverse pulmonary hypertension. Stem Cells 29: 99-107.
26. Xu, J, Mora, A, Shim, H, Stecenko, A, Brigham, KL and Rojas, M (2007). Role of the SDF-1/CXCR4 axis in the pathogenesis of lung injury and fbrosis. Am J Respir Cell Mol Biol 37: 291-299.
27. Wynn, TA (2007). Common and unique mechanisms regulate fbrosis in various fbroproliferative diseases. J Clin Invest 117: 524-529.
28. Yan, X, Liu, Y, Han, Q, Jia, M, Liao, L, Qi, M et al. (2007). Injured microenvironment directly guides the differentiation of engrafted Flk-1(+) mesenchymal stem cell in lung. Exp Hematol 35: 1466-1475.
29. Kim, CF, Jackson, EL, Woolfenden, AE, Lawrence, S, Babar, I, Vogel, S et al. (2005). Identifcation of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121: 823-835.
30. Lee, JW, Fang, X, Gupta, N, Serikov, V and Matthay, MA (2009). Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci USA 106: 16357-16362.
31. Ortiz, LA, Dutreil, M, Fattman, C, Pandey, AC, Torres, G, Go, K et al. (2007). Interleukin 1 receptor antagonist mediates the antiinfammatory and antifbrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA 104: 11002-11007.
32. Aguilar, S, Nye, E, Chan, J, Loebinger, M, Spencer-Dene, B, Fisk, N et al. (2007). Murine but not human mesenchymal stem cells generate osteosarcoma-like lesions in the lung. Stem Cells 25: 1586-1594.
33. Tolar, J, Nauta, AJ, Osborn, MJ, Panoskaltsis Mortari, A, McElmurry, RT, Bell, S et al. (2007). Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 25: 371-379.
34. Sasportas, LS, Kasmieh, R, Wakimoto, H, Hingtgen, S, van de Water, JA, Mohapatra, G et al. (2009). Assessment of therapeutic effcacy and fate of engineered human mesenchymal stem cells for cancer therapy. Proc Natl Acad Sci USA 106: 4822-4827.
35. Klopp, AH, Spaeth, EL, Dembinski, JL, Woodward, WA, Munshi, A, Meyn, RE et al. (2007). Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment. Cancer Res 67: 11687-11695.
36. Zielske, SP, Livant, DL and Lawrence, TS (2009). Radiation increases invasion of gene-modifed mesenchymal stem cells into tumors. Int J Radiat Oncol Biol Phys 75: 843-853.
37. Kursova, LV, Konoplyannikov, AG, Pasov, VV, Ivanova, IN, Poluektova, MV and Konoplyannikova, OA (2009). Possibilities for the use of autologous mesenchymal stem cells in the therapy of radiation-induced lung injuries. Bull Exp Biol Med 147: 542-546.
38. Sugahara, K, Tokumine, J, Teruya, K and Oshiro, T (2006). Alveolar epithelial cells: differentiation and lung injury. Respirology 11 Suppl: S28-S31.
39. Harris, RG, Herzog, EL, Bruscia, EM, Grove, JE, Van Arnam, JS and Krause, DS (2004). Lack of a fusion requirement for development of bone marrow-derived epithelia. Science 305: 90-93.
40. Krause, DS, Theise, ND, Collector, MI, Henegariu, O, Hwang, S, Gardner, R et al. (2001). Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105: 369-377.
41. Chang, JC, Summer, R, Sun, X, Fitzsimmons, K and Fine, A (2005). Evidence that bone marrow cells do not contribute to the alveolar epithelium. Am J Respir Cell Mol Biol 33: 335-342.
42. Kotton, DN, Fabian, AJ and Mulligan, RC (2005). Failure of bone marrow to reconstitute lung epithelium. Am J Respir Cell Mol Biol 33: 328-334.
43. Aliotta, JM, Sanchez-Guijo, FM, Dooner, GJ, Johnson, KW, Dooner, MS, Greer, KA et al. (2007). Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation. Stem Cells 25: 2245-2256.
44. Weiss, DJ, Kolls, JK, Ortiz, LA, Panoskaltsis-Mortari, A and Prockop, DJ (2008). Stem cells and cell therapies in lung biology and lung diseases. Proc Am Thorac Soc 5: 637-667.
45. Németh, K, Leelahavanichkul, A, Yuen, PS, Mayer, B, Parmelee, A, Doi, K et al. (2009). Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15: 42-49.
46. Lee, RH, Pulin, AA, Seo, MJ, Kota, DJ, Ylostalo, J, Larson, BL et al. (2009). Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-infammatory protein TSG-6. Cell Stem Cell 5: 54-63.